Skip to content
← Full study record

NCT02604511 · MORE INFO

Limitations, agreements, and source contact

Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing · Source last updated 2022-12-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
steven_treon@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617-632-2681
title
Dr. Steven Treon
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
steven_treon@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617-632-2681
title
Dr. Steven Treon

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice